Detalle Publicación

ARTÍCULO
Characteristics of the case mix, organisation and delivery in cancer palliative care: a challenge for good-quality research
Autores: Hjermstad, MJ; Aass, N; Aielli, F; Bennett, M; Brunelli, C; Caraceni, A; Cavanna, L; Fassbender, K; Feio, M; Haugen, D.F; Jakobsen, G; Laird, B; Lohre, ET; Martínez García, Marina; Nabal, M; Noguera Tejedor, Antonio Luís; Pardon, K; Pigni, A; Piva, L; Porta-Sales, J; Rizzi, F; Rondini, E; Sjogren, P; Strasser, F; Turriziani, A; Kaasa, S; European Palliative Care Cancer Symptom study (EPC
Título de la revista: BMJ SUPPORTIVE & PALLIATIVE CARE
ISSN: 2045-435X
Volumen: 8
Número: 4
Páginas: 456 - 467
Fecha de publicación: 2018
Resumen:
Objectives Palliative care (PC) services and patients differ across countries. Data on PC delivery paired with medical and self-reported data are seldom reported. Aims were to describe (1) PC organisation and services in participating centres and (2) characteristics of patients in PC programmes. Methods This was an international prospective multicentre study with a single web-based survey on PC organisation, services and academics and patients¿ self-reported symptoms collected at baseline and monthly thereafter, with concurrent registrations of medical data by healthcare providers. Participants were patients ¿18 enrolled in a PC programme. Results 30 centres in 12 countries participated; 24 hospitals, 4 hospices, 1 nursing home, 1 home-care service. 22 centres (73%) had PC in-house teams and inpatient and outpatient services. 20 centres (67%) had integral chemotherapy/radiotherapy services, and most (28/30) had access to general medical or oncology inpatient units. Physicians or nurses were present 24 hours/7 days in 50% and 60% of centres, respectively. 50 centres (50%) had professorships, and 12 centres (40%) had full- time/part-time research staff. Data were available on 1698 patients: 50% females; median age 66 (range 21¿97); median Karnofsky score 70 (10¿ 100); 1409 patients (83%) had metastatic/ disseminated disease; tiredness and pain in the past 24 hours were most prominent. During follow-up, 1060 patients (62%) died; 450 (44%) <3 months from inclusion and 701 (68%)